# Risk of Acute Liver Injury in Users of Antimicrobials

> **NCT01434173** · — · COMPLETED · sponsor: **Bayer** · enrollment: 1299056 (actual)

## Conditions studied

- Drug-Induced Liver Injury

## Interventions

- **DRUG:** Moxifloxacin (Avelox, BAY12-8039)
- **DRUG:** Amoxicillin, Amoxicillin plus clavulanic acid, Cefuroxime, Clarithromycin, Doxycycline, Levofloxacin, Telithromycin

## Key facts

- **NCT ID:** NCT01434173
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 1299056 (ACTUAL)
- **Last updated:** 2014-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434173, "Risk of Acute Liver Injury in Users of Antimicrobials". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01434173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*